Plain-English translation of NCT06953349 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial looks at how well three surgical procedures work together to treat open-angle glaucoma—a common eye condition where pressure inside the eye builds up and can damage vision. The combination includes cataract removal surgery, a procedure to open the eye's drainage system, and a tiny device called the Hydrus microstent. Researchers are reviewing medical records from patients who have already had all three procedures to see how well this combination lowers eye pressure.
Many people with glaucoma need to take multiple eye drops to control pressure, which can be inconvenient and may not always work well enough. This trial explores whether combining these three surgical approaches might be more effective at lowering eye pressure in a diverse group of patients.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, which means you would not receive new treatment—instead, researchers would review your existing medical records if you had already undergone the combination surgery. You would need to have at least 3 years of follow-up data from your surgery, including eye pressure measurements and vision tests. The study team would analyze this information to see how well the combination approach worked for you and other patients.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Barnet Dulaney Perkins Eye Centers
Collaborators
Alcon, a Novartis Company
Enrollment target
~300 participants
Started
March 2025
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Derek J Arnson, Master of Education
Barnet Dulaney Perkins Eye Centers
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.